Robert Lim
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cystic Fibrosis Research Advances 2
- Inhalation and Respiratory Drug Delivery 1
- Oncology 3
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Eric Van Cutsem (3 shared papers)Christopher Stroh (2 shared papers)Tamás Pintér (2 shared papers)G. Bodoky (2 shared papers)Sabine Tejpar (1 shared paper)Gunnar Folprecht (1 shared paper)Geert D’Haens (1 shared paper)Philippe Rougier (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)New England Journal of Medicine (2 papers)Therapeutic Innovation & Regulatory Science (1 paper)The Cancer Journal (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesSingaporeHungary
In The Last Decade
Robert Lim
9 papers receiving 3.3k citations
Robert Lim's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 2.3k
- Hepatology 559
- Pathology and Forensic Medicine 496
- Pulmonary and Respiratory Medicine 807
- Cancer Research 369
Countries citing papers authored by Robert Lim
This map shows the geographic impact of Robert Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lim more than expected).
Fields of papers citing papers by Robert Lim
This network shows the impact of papers produced by Robert Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lim. The network helps show where Robert Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 3017 |
| 2 | 2006 | 218 | |
| 3 | 2017 | 105 | |
| 4 | 2009 | 23 | |
| 5 | 2008 | 23 | |
| 6 | 2018 | 17 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 2 | |
| 9 | 2025 | 1 |
About Robert Lim
Robert Lim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Genetics and Pathology and Forensic Medicine, having authored 9 papers that have together received 3.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cystic Fibrosis Research Advances (2 papers), Genomics and Rare Diseases (1 paper), Cancer Genomics and Diagnostics (1 paper), Genetic Syndromes and Imprinting (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (2.3k citations), Hepatology (559 citations), Pathology and Forensic Medicine (496 citations), Pulmonary and Respiratory Medicine (807 citations) and Cancer Research (369 citations). Robert Lim has collaborated with scholars based in United States, Singapore and Hungary. Frequent co-authors include Eric Van Cutsem, Christopher Stroh, Tamás Pintér, G. Bodoky, Sabine Tejpar, Gunnar Folprecht, Geert D’Haens, Philippe Rougier, Michael Schlichting and Erika Hitre. Their work appears in journals such as Journal of Clinical Oncology, New England Journal of Medicine, Therapeutic Innovation & Regulatory Science, The Cancer Journal and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.